Female health workers need better radiation protection to minimize breast cancer risk, find researchers

by British Medical JournalCredit: Unsplash/CC0 Public DomainWomen working in health care who are regularly exposed to radiation from X-rays and other imaging procedures need better ionizing radia

Updated on: February 01,2024

Female health workers need better radiation protection to minimize breast cancer risk, find researchers

by British Medical JournalCredit: Unsplash/CC0 Public DomainWomen working in health care who are regularly exposed to radiation from X-rays and other imaging procedures need better ionizing radia

Updated on:February 01,2024

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred

Updated on: January 02,2024

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred

Updated on:January 02,2024

New treatments, screening methods dramatically reduce breast cancer deaths, study finds

by Stanford University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainIn the last few decades, dozens of new breast cancer drugs—fr

Updated on: March 01,2024

New treatments, screening methods dramatically reduce breast cancer deaths, study finds

by Stanford University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainIn the last few decades, dozens of new breast cancer drugs—fr

Updated on:March 01,2024

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on: December 28,2023

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on:December 28,2023

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic

Updated on: February 18,2024

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic

Updated on:February 18,2024

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on: May 09,2024

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on:May 09,2024

Depression affects one-third of lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityCredit: CC0 Public DomainAbout one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depre

Updated on: May 11,2024

Depression affects one-third of lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityCredit: CC0 Public DomainAbout one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depre

Updated on:May 11,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on: January 29,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on:January 29,2024

Epigenetic drugs in the mission to beat rare cancers

by Simon Schmitt,Helmholtz Association of German Research CentresViability, SSTR2 protein levels, and [68Ga]Ga-DOTA-TATE uptake of MPC and MTT cells treated with epigenetic drugs; (A) Sequence o

Updated on: February 20,2024

Epigenetic drugs in the mission to beat rare cancers

by Simon Schmitt,Helmholtz Association of German Research CentresViability, SSTR2 protein levels, and [68Ga]Ga-DOTA-TATE uptake of MPC and MTT cells treated with epigenetic drugs; (A) Sequence o

Updated on:February 20,2024

AI tool developed to help grade cancer based on cell divisions

by University of WarwickCells dividing under the microscope. Credit: University of WarwickAhead of World Cancer Day on 4 February, scientists are revealing a cutting-edge artificial intelligence

Updated on: March 05,2024

AI tool developed to help grade cancer based on cell divisions

by University of WarwickCells dividing under the microscope. Credit: University of WarwickAhead of World Cancer Day on 4 February, scientists are revealing a cutting-edge artificial intelligence

Updated on:March 05,2024

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on: August 27,2024

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on:August 27,2024

Expert panel updates cancer and aging guidelines

byCity of Hope National Medical CenterWilliam Dale, M.D., Ph.D., City of Hope’s George Tsai Family Chair in Geriatric Oncology in Honor of Arti Hurria, M.D., says, "The geriatric assessment

Updated on: January 22,2024

Expert panel updates cancer and aging guidelines

byCity of Hope National Medical CenterWilliam Dale, M.D., Ph.D., City of Hope’s George Tsai Family Chair in Geriatric Oncology in Honor of Arti Hurria, M.D., says, "The geriatric assessment

Updated on:January 22,2024